Anterior Chamber Paracentesis Facilitates Laser Peripheral Iridotomy and Restores Vision in Mild-to-moderate Acute Primary Angle-closure Glaucoma

Chieh Feng Cheng, Chen Lon Tsai, Oscar Kuang Sheng Lee, Jung Jen Feng, Jennifer Hui Chun Ho

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Acute primary angle-closure glaucoma (PACG) is an ocular emergency that commonly presents in Asian populations. For patients with contraindications for mannitol infusion, it is imperative to perform an alternative therapy in order to rapidly decrease intraocular pressure (IOP) and prevent further visual complications. The purpose of this study is to evaluate the therapeutic efficiency of anterior chamber paracentesis (ACP) and mannitol infusion in patients with PACG. Methods: Patients who suffered from their first attack of acute PACG when receiving ACP or mannitol infusion (20%, 300mL) were included. They were divided into three subgroups: mild, moderate, or severe acute PACG, according to each patient's initial IOP upon presentation (mild group, 45-50mmHg; moderate group, 50-60mmHg; severe group, >60mmHg). IOP at multiple time points, best-corrected visual acuity (BCVA), severity of corneal edema, and waiting time for laser peripheral iridotomy (LPI) were recorded. Results: Compared with mannitol infusion (n=29), ACP treatment (n=30) achieved more rapid and effective IOP control within 2 hours, resulted in faster regression of corneal edema (grade: 0.98±0.729 [ACP] vs. 1.50±0.720 [mannitol], p=0.011), and patients were able to undergo LPI within a reasonable amount of time (1.4±0.93 days [ACP] vs. 2.5±1.17 days [mannitol], p=0.0002). All patients who received ACP or mannitol demonstrated improved BCVA within 2 weeks. Intriguingly, ACP restored visual acuity more effectively than mannitol infusion in patients with an initial IOP lower than 60mmHg. Conclusion: ACP effectively treats acute PACG by rapidly stabilizing the anterior chamber. When the initial IOP is above 60mmHg, ACP should only be considered when mannitol is contraindicated.

Original languageEnglish
Pages (from-to)52-57
Number of pages6
JournalJournal of Experimental and Clinical Medicine(Taiwan)
Volume4
Issue number1
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Paracentesis
Angle Closure Glaucoma
Anterior Chamber
Mannitol
Lasers
Intraocular Pressure
Visual Acuity
Corneal Edema
Complementary Therapies
Emergencies

Keywords

  • Acute primary angle-closure glaucoma
  • Anterior chamber paracentesis
  • Intraocular pressure
  • Mannitol infusion
  • Visual acuity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Anterior Chamber Paracentesis Facilitates Laser Peripheral Iridotomy and Restores Vision in Mild-to-moderate Acute Primary Angle-closure Glaucoma. / Cheng, Chieh Feng; Tsai, Chen Lon; Lee, Oscar Kuang Sheng; Feng, Jung Jen; Ho, Jennifer Hui Chun.

In: Journal of Experimental and Clinical Medicine(Taiwan), Vol. 4, No. 1, 02.2012, p. 52-57.

Research output: Contribution to journalArticle

@article{81a624909de24105824555bb25664731,
title = "Anterior Chamber Paracentesis Facilitates Laser Peripheral Iridotomy and Restores Vision in Mild-to-moderate Acute Primary Angle-closure Glaucoma",
abstract = "Purpose: Acute primary angle-closure glaucoma (PACG) is an ocular emergency that commonly presents in Asian populations. For patients with contraindications for mannitol infusion, it is imperative to perform an alternative therapy in order to rapidly decrease intraocular pressure (IOP) and prevent further visual complications. The purpose of this study is to evaluate the therapeutic efficiency of anterior chamber paracentesis (ACP) and mannitol infusion in patients with PACG. Methods: Patients who suffered from their first attack of acute PACG when receiving ACP or mannitol infusion (20{\%}, 300mL) were included. They were divided into three subgroups: mild, moderate, or severe acute PACG, according to each patient's initial IOP upon presentation (mild group, 45-50mmHg; moderate group, 50-60mmHg; severe group, >60mmHg). IOP at multiple time points, best-corrected visual acuity (BCVA), severity of corneal edema, and waiting time for laser peripheral iridotomy (LPI) were recorded. Results: Compared with mannitol infusion (n=29), ACP treatment (n=30) achieved more rapid and effective IOP control within 2 hours, resulted in faster regression of corneal edema (grade: 0.98±0.729 [ACP] vs. 1.50±0.720 [mannitol], p=0.011), and patients were able to undergo LPI within a reasonable amount of time (1.4±0.93 days [ACP] vs. 2.5±1.17 days [mannitol], p=0.0002). All patients who received ACP or mannitol demonstrated improved BCVA within 2 weeks. Intriguingly, ACP restored visual acuity more effectively than mannitol infusion in patients with an initial IOP lower than 60mmHg. Conclusion: ACP effectively treats acute PACG by rapidly stabilizing the anterior chamber. When the initial IOP is above 60mmHg, ACP should only be considered when mannitol is contraindicated.",
keywords = "Acute primary angle-closure glaucoma, Anterior chamber paracentesis, Intraocular pressure, Mannitol infusion, Visual acuity",
author = "Cheng, {Chieh Feng} and Tsai, {Chen Lon} and Lee, {Oscar Kuang Sheng} and Feng, {Jung Jen} and Ho, {Jennifer Hui Chun}",
year = "2012",
month = "2",
doi = "10.1016/j.jecm.2011.11.009",
language = "English",
volume = "4",
pages = "52--57",
journal = "Journal of Experimental and Clinical Medicine",
issn = "1878-3317",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Anterior Chamber Paracentesis Facilitates Laser Peripheral Iridotomy and Restores Vision in Mild-to-moderate Acute Primary Angle-closure Glaucoma

AU - Cheng, Chieh Feng

AU - Tsai, Chen Lon

AU - Lee, Oscar Kuang Sheng

AU - Feng, Jung Jen

AU - Ho, Jennifer Hui Chun

PY - 2012/2

Y1 - 2012/2

N2 - Purpose: Acute primary angle-closure glaucoma (PACG) is an ocular emergency that commonly presents in Asian populations. For patients with contraindications for mannitol infusion, it is imperative to perform an alternative therapy in order to rapidly decrease intraocular pressure (IOP) and prevent further visual complications. The purpose of this study is to evaluate the therapeutic efficiency of anterior chamber paracentesis (ACP) and mannitol infusion in patients with PACG. Methods: Patients who suffered from their first attack of acute PACG when receiving ACP or mannitol infusion (20%, 300mL) were included. They were divided into three subgroups: mild, moderate, or severe acute PACG, according to each patient's initial IOP upon presentation (mild group, 45-50mmHg; moderate group, 50-60mmHg; severe group, >60mmHg). IOP at multiple time points, best-corrected visual acuity (BCVA), severity of corneal edema, and waiting time for laser peripheral iridotomy (LPI) were recorded. Results: Compared with mannitol infusion (n=29), ACP treatment (n=30) achieved more rapid and effective IOP control within 2 hours, resulted in faster regression of corneal edema (grade: 0.98±0.729 [ACP] vs. 1.50±0.720 [mannitol], p=0.011), and patients were able to undergo LPI within a reasonable amount of time (1.4±0.93 days [ACP] vs. 2.5±1.17 days [mannitol], p=0.0002). All patients who received ACP or mannitol demonstrated improved BCVA within 2 weeks. Intriguingly, ACP restored visual acuity more effectively than mannitol infusion in patients with an initial IOP lower than 60mmHg. Conclusion: ACP effectively treats acute PACG by rapidly stabilizing the anterior chamber. When the initial IOP is above 60mmHg, ACP should only be considered when mannitol is contraindicated.

AB - Purpose: Acute primary angle-closure glaucoma (PACG) is an ocular emergency that commonly presents in Asian populations. For patients with contraindications for mannitol infusion, it is imperative to perform an alternative therapy in order to rapidly decrease intraocular pressure (IOP) and prevent further visual complications. The purpose of this study is to evaluate the therapeutic efficiency of anterior chamber paracentesis (ACP) and mannitol infusion in patients with PACG. Methods: Patients who suffered from their first attack of acute PACG when receiving ACP or mannitol infusion (20%, 300mL) were included. They were divided into three subgroups: mild, moderate, or severe acute PACG, according to each patient's initial IOP upon presentation (mild group, 45-50mmHg; moderate group, 50-60mmHg; severe group, >60mmHg). IOP at multiple time points, best-corrected visual acuity (BCVA), severity of corneal edema, and waiting time for laser peripheral iridotomy (LPI) were recorded. Results: Compared with mannitol infusion (n=29), ACP treatment (n=30) achieved more rapid and effective IOP control within 2 hours, resulted in faster regression of corneal edema (grade: 0.98±0.729 [ACP] vs. 1.50±0.720 [mannitol], p=0.011), and patients were able to undergo LPI within a reasonable amount of time (1.4±0.93 days [ACP] vs. 2.5±1.17 days [mannitol], p=0.0002). All patients who received ACP or mannitol demonstrated improved BCVA within 2 weeks. Intriguingly, ACP restored visual acuity more effectively than mannitol infusion in patients with an initial IOP lower than 60mmHg. Conclusion: ACP effectively treats acute PACG by rapidly stabilizing the anterior chamber. When the initial IOP is above 60mmHg, ACP should only be considered when mannitol is contraindicated.

KW - Acute primary angle-closure glaucoma

KW - Anterior chamber paracentesis

KW - Intraocular pressure

KW - Mannitol infusion

KW - Visual acuity

UR - http://www.scopus.com/inward/record.url?scp=84856211967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856211967&partnerID=8YFLogxK

U2 - 10.1016/j.jecm.2011.11.009

DO - 10.1016/j.jecm.2011.11.009

M3 - Article

AN - SCOPUS:84856211967

VL - 4

SP - 52

EP - 57

JO - Journal of Experimental and Clinical Medicine

JF - Journal of Experimental and Clinical Medicine

SN - 1878-3317

IS - 1

ER -